Rigel Pharmaceuticals, Inc. RIGL
41.83 USD +2.18 (+5.50%)
Nov 9, 2026, 2:10 PM EST
39.50 Day range 41.92
24.95 52-week range 52.61
- YTD
- -2.33%
- 1 year
- +18.87%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 294.28M | 179.28M | 116.88M | 120.24M | 149.24M | |
| 274.66M | 160.63M | 109.77M | 118.49M | 148.15M | |
| 125.47M | 24.19M | -20.49M | -55.55M | -12.50M | |
| 367.02M | 17.48M | -25.09M | -58.57M | -17.91M | |
| 19.48 | 0.99 | -1.44 | -3.44 | -1.10 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 40.58M | 56.75M | 32.79M | 24.46M | 18.89M | |
| 513.59M | 163.98M | 117.22M | 134.28M | 167.33M | |
| 122.11M | 160.69M | 145.87M | 147.90M | 136.95M | |
| 53.30M | 59.97M | 60.58M | 41.55M | 30.57M | |
| 391.48M | 3.29M | -28.64M | -13.62M | 30.37M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 75.66M | 31.47M | -5.74M | -73.76M | 5.88M | |
| -92.36M | 4.13M | -4.30M | 72.78M | -80.04M | |
| 601.00K | -11.64M | 18.37M | 6.55M | 62.67M | |
| -16.11M | 23.96M | 8.33M | 5.57M | -11.48M |